Published in J Biol Chem on June 15, 2010
Characterization of the envelope glycoproteins associated with infectious hepatitis C virus. J Virol (2010) 1.59
Hepatitis C virus, cholesterol and lipoproteins--impact for the viral life cycle and pathogenesis of liver disease. Viruses (2013) 1.12
The association of hepatitis C virus glycoproteins with apolipoproteins E and B early in assembly is conserved in lipoviral particles. J Biol Chem (2014) 0.93
Entry inhibitors: New advances in HCV treatment. Emerg Microbes Infect (2016) 0.84
Lipoprotein receptors and lipid enzymes in hepatitis C virus entry and early steps of infection. Scientifica (Cairo) (2012) 0.77
Last stop before exit - hepatitis C assembly and release as antiviral drug targets. Viruses (2010) 0.75
Complete replication of hepatitis C virus in cell culture. Science (2005) 18.59
Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat Biotechnol (1997) 12.11
Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology (2005) 9.39
Replication of hepatitis C virus. Nat Rev Microbiol (2007) 8.31
Epidemiology of hepatitis C virus infection. World J Gastroenterol (2007) 7.36
Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor. Proc Natl Acad Sci U S A (1999) 6.05
Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat. Nat Genet (2000) 5.23
Characterization of low- and very-low-density hepatitis C virus RNA-containing particles. J Virol (2002) 4.55
Fluorescence method for measuring the kinetics of fusion between biological membranes. Biochemistry (1984) 4.44
Equilibrium centrifugation studies of hepatitis C virus: evidence for circulating immune complexes. J Virol (1993) 4.13
Association of hepatitis C virus in human sera with beta-lipoprotein. Med Microbiol Immunol (1992) 3.59
Cellular determinants of hepatitis C virus assembly, maturation, degradation, and secretion. J Virol (2007) 3.57
Lipids in biological membrane fusion. J Membr Biol (1995) 3.40
Human apolipoprotein e is required for infectivity and production of hepatitis C virus in cell culture. J Virol (2007) 3.18
Development and characterization of hepatitis C virus genotype 1-7 cell culture systems: role of CD81 and scavenger receptor class B type I and effect of antiviral drugs. Hepatology (2009) 3.10
Association between hepatitis C virus and very-low-density lipoprotein (VLDL)/LDL analyzed in iodixanol density gradients. J Virol (2006) 2.88
The low-density lipoprotein receptor plays a role in the infection of primary human hepatocytes by hepatitis C virus. J Hepatol (2006) 2.74
Characterization of hepatitis C virus (HCV) and HCV E2 interactions with CD81 and the low-density lipoprotein receptor. J Virol (2000) 2.50
Characterization of functional hepatitis C virus envelope glycoproteins. J Virol (2004) 2.40
Structure of apolipoprotein B-100 in low density lipoproteins. J Lipid Res (2001) 2.25
Studies on the mechanism of membrane fusion: kinetics of calcium ion induced fusion of phosphatidylserine vesicles followed by a new assay for mixing of aqueous vesicle contents. Biochemistry (1980) 2.06
Apolipoprotein E but not B is required for the formation of infectious hepatitis C virus particles. J Virol (2009) 2.00
Resistance to diet-induced hypercholesterolemia and gallstone formation in ACAT2-deficient mice. Nat Med (2000) 1.94
Hepatitis C virus: buoyant density of the factor VIII-derived isolate in sucrose. J Med Virol (1991) 1.93
Hepatitis C virus particles and lipoprotein metabolism. Semin Liver Dis (2005) 1.74
Apolipoprotein E on hepatitis C virion facilitates infection through interaction with low-density lipoprotein receptor. Virology (2009) 1.72
Apolipoprotein E interacts with hepatitis C virus nonstructural protein 5A and determines assembly of infectious particles. Hepatology (2010) 1.65
Plasma lipoproteins in familial lecithin: cholesterol acyltransferase deficiency: structure of low and high density lipoproteins as revealed by elctron microscopy. J Clin Invest (1971) 1.63
Lipid droplets as dynamic organelles connecting storage and efflux of lipids. Biochim Biophys Acta (2008) 1.60
Structure of low density lipoprotein (LDL) particles: basis for understanding molecular changes in modified LDL. Biochim Biophys Acta (2000) 1.59
The plasma lipoproteins: structure and metabolism. Annu Rev Biochem (1978) 1.54
Ca2+-induced fusion of phospholipid vesicles monitored by mixing of aqueous contents. Nature (1979) 1.44
Characterization of monoclonal antibodies against human low density lipoprotein. Arteriosclerosis (1983) 1.44
Hepatitis C virus glycoproteins mediate low pH-dependent membrane fusion with liposomes. J Biol Chem (2005) 1.41
Preferential association of Hepatitis C virus with apolipoprotein B48-containing lipoproteins. J Gen Virol (2006) 1.39
Hepatitis C virus particles of different density in the blood of chronically infected immunocompetent and immunodeficient patients: Implications for virus clearance by antibody. J Med Virol (2002) 1.32
Secretion of hepatitis C virus envelope glycoproteins depends on assembly of apolipoprotein B positive lipoproteins. PLoS One (2009) 1.31
Model of human low-density lipoprotein and bound receptor based on cryoEM. Proc Natl Acad Sci U S A (2009) 1.27
Low pH-dependent hepatitis C virus membrane fusion depends on E2 integrity, target lipid composition, and density of virus particles. J Biol Chem (2009) 1.14
Cryo-electron microscopy of low density lipoprotein and reconstituted discoidal high density lipoprotein: imaging of the apolipoprotein moiety. J Lipid Res (1997) 1.01
Lentiviral transduction of human hematopoietic cells by HIV-1- and SIV-based vectors containing a bicistronic cassette driven by various internal promoters. J Gene Med (2005) 0.96
Cryo-electron microscopy reveals human low density lipoprotein substructure. J Lipid Res (1994) 0.93
Characterization of antigenic determinants of human apolipoprotein B. Distribution on tryptic fragments of low density lipoprotein. Arteriosclerosis (1984) 0.86
Peptide inhibitors of enveloped virus infection inhibit phospholipid vesicle fusion and Sendai virus fusion with phospholipid vesicles. J Biol Chem (1990) 0.83
Characterization of hepatitis C virus pseudoparticles by cryo-transmission electron microscopy using functionalized magnetic nanobeads. J Gen Virol (2010) 0.83
Transmission of low-density hepatitis C viral particles during sexually transmitted acute resolving infection. J Med Virol (2008) 0.82
A study of carbobenzoxy-D-phenylalanine-L-phenylalanine-glycine, an inhibitor of membrane fusion, in phospholipid bilayers with multinuclear magnetic resonance. Biochim Biophys Acta (1995) 0.82
HCV research 20 years after discovery: a summary of the 16th international symposium on hepatitis C virus and related viruses. Gastroenterology (2009) 0.77
Assembly of infectious hepatitis C virus particles. Trends Microbiol (2010) 2.36
IRGM is a common target of RNA viruses that subvert the autophagy network. PLoS Pathog (2011) 2.09
VirHostNet: a knowledge base for the management and the analysis of proteome-wide virus-host interaction networks. Nucleic Acids Res (2008) 1.71
French national sentinel survey of antiretroviral drug resistance in patients with HIV-1 primary infection and in antiretroviral-naive chronically infected patients in 2001-2002. J Acquir Immune Defic Syndr (2005) 1.63
Characterization of fusion determinants points to the involvement of three discrete regions of both E1 and E2 glycoproteins in the membrane fusion process of hepatitis C virus. J Virol (2007) 1.59
Preferential association of Hepatitis C virus with apolipoprotein B48-containing lipoproteins. J Gen Virol (2006) 1.39
A nonionic amphiphile agent promotes gene delivery in vivo to skeletal and cardiac muscles. Hum Gene Ther (2002) 1.37
Secretion of hepatitis C virus envelope glycoproteins depends on assembly of apolipoprotein B positive lipoproteins. PLoS One (2009) 1.31
The exchangeable apolipoprotein ApoC-I promotes membrane fusion of hepatitis C virus. J Biol Chem (2007) 1.21
Strand specific quantitative real-time PCR to study replication of hepatitis C virus genome. J Virol Methods (2004) 1.21
The formation of supported lipid bilayers on silica nanoparticles revealed by cryoelectron microscopy. Nano Lett (2005) 1.19
1-Methyl-tryptophan can interfere with TLR signaling in dendritic cells independently of IDO activity. J Immunol (2006) 1.15
Mapping of Chikungunya virus interactions with host proteins identified nsP2 as a highly connected viral component. J Virol (2012) 1.12
HIV-1 load comparison using four commercial real-time assays. J Clin Microbiol (2010) 1.12
Self-assembled lamellar complexes of siRNA with lipidic aminoglycoside derivatives promote efficient siRNA delivery and interference. Proc Natl Acad Sci U S A (2007) 1.08
Multi-residue analysis of 80 environmental contaminants in honeys, honeybees and pollens by one extraction procedure followed by liquid and gas chromatography coupled with mass spectrometric detection. J Chromatogr A (2011) 1.05
Expression of hepatitis C virus proteins in epithelial intestinal cells in vivo. J Gen Virol (2004) 1.03
The motor protein myosin-X transports VE-cadherin along filopodia to allow the formation of early endothelial cell-cell contacts. Mol Cell Biol (2010) 1.03
Negatively charged self-assembling DNA/poloxamine nanospheres for in vivo gene transfer. Nucleic Acids Res (2004) 1.02
Mature dendritic cell generation promoted by lysophosphatidylcholine. J Immunol (2002) 1.01
Asymmetrical membranes and surface tension. Biophys J (2002) 1.01
Enhancement of genotype 1 hepatitis C virus replication by bile acids through FXR. J Hepatol (2007) 0.98
The interactomes of influenza virus NS1 and NS2 proteins identify new host factors and provide insights for ADAR1 playing a supportive role in virus replication. PLoS Pathog (2013) 0.97
Biochemical mechanism of hepatitis C virus inhibition by the broad-spectrum antiviral arbidol. Biochemistry (2007) 0.96
Different effects of the TAR structure on HIV-1 and HIV-2 genomic RNA translation. Nucleic Acids Res (2011) 0.94
Clearance of serum HBsAg and anti-HBs seroconversion following antiviral therapy for chronic hepatitis B. J Med Virol (2009) 0.93
Expected response to protease inhibitors of HIV-1 non-B subtype viruses according to resistance algorithms. AIDS (2008) 0.93
Structure of reconstituted bacterial membrane efflux pump by cryo-electron tomography. Biochim Biophys Acta (2010) 0.93
Cancer-specific transgene expression mediated by systemic injection of nanoparticles. Cancer Res (2009) 0.92
Synthesis and self-assembly of branched glycopolypeptides: effect of topology and conformation. Faraday Discuss (2013) 0.92
Sensing environmental lipids by dendritic cell modulates its function. J Immunol (2004) 0.92
Lysophosphatidylcholine is a natural adjuvant that initiates cellular immune responses. Vaccine (2005) 0.92
Cryo-electron tomography of nanoparticle transmigration into liposome. J Struct Biol (2009) 0.91
Viruses and interactomes in translation. Mol Cell Proteomics (2012) 0.91
A chemical synthetic route towards "colloidal molecules". Angew Chem Int Ed Engl (2009) 0.91
Transactivation of the hepatitis B virus core promoter by the nuclear receptor FXRalpha. J Virol (2008) 0.90
Membrane protein selectively oriented on solid support and reconstituted into a lipid membrane. Langmuir (2007) 0.89
Prediction of the virological response to etravirine in clinical practice: Comparison of three genotype algorithms. J Med Virol (2009) 0.89
The encapsulation of DNA molecules within biomimetic lipid nanocapsules. Biomaterials (2009) 0.89
Activity of hexokinase is increased by its interaction with hepatitis C virus protein NS5A. J Virol (2014) 0.89
Sensitive and reliable JC-1 and TOTO-3 double staining to assess mitochondrial transmembrane potential and plasma membrane integrity: interest for cell death investigations. Cytometry A (2003) 0.89
Secretory phospholipase A2 induces dendritic cell maturation. Eur J Immunol (2004) 0.88
Treatment of influenza virus with beta-propiolactone alters viral membrane fusion. Biochim Biophys Acta (2013) 0.87
New horizons for antiviral drug discovery from virus-host protein interaction networks. Curr Opin Virol (2012) 0.87
High plasma level of nucleocapsid-free envelope glycoprotein-positive lipoproteins in hepatitis C patients. Hepatology (2012) 0.87
Genetic screens for the control of influenza virus replication: from meta-analysis to drug discovery. Mol Biosyst (2012) 0.87
Annexin-A6 presents two modes of association with phospholipid membranes. A combined QCM-D, AFM and cryo-TEM study. J Struct Biol (2009) 0.87
The homeodomain derived peptide Penetratin induces curvature of fluid membrane domains. PLoS One (2008) 0.86
Th1 disabled function in response to TLR4 stimulation of monocyte-derived DC from patients chronically-infected by hepatitis C virus. PLoS One (2008) 0.86
Standardized one-step real-time reverse transcription-PCR assay for universal detection and quantification of hepatitis delta virus from clinical samples in the presence of a heterologous internal-control RNA. J Clin Microbiol (2012) 0.86
The metabolic sensors FXRα, PGC-1α, and SIRT1 cooperatively regulate hepatitis B virus transcription. FASEB J (2013) 0.86
Modified lipoproteins provide lipids that modulate dendritic cell immune function. Biochimie (2012) 0.85
Failure and success of HIV tests for the prevention of HIV-1 transmission by blood and tissue donations. J Med Virol (2004) 0.85
Hepatitis C lipo-Viro-particle from chronically infected patients interferes with TLR4 signaling in dendritic cell. PLoS One (2007) 0.85
Non-targeted molecular characterisation of a rose flower ethyl acetate extract using Ultra-HPLC with atmospheric pressure photoionisation and quadrupole time-of-flight MS/MS. Phytochem Anal (2015) 0.84
Structure of artificial and natural VE-cadherin-based adherens junctions. Biochem Soc Trans (2008) 0.84
Discordance in HIV-1 co-receptor use prediction by different genotypic algorithms and phenotype assay: intermediate profile in relation to concordant predictions. J Med Virol (2012) 0.84
Low-level viremia is associated with non-B subtypes in patients infected with HIV with virological success following HAART introduction. J Med Virol (2013) 0.83
The enhanced membrane interaction and perturbation of a cell penetrating peptide in the presence of anionic lipids: toward an understanding of its selectivity for cancer cells. Biochim Biophys Acta (2013) 0.83
Structure homology and interaction redundancy for discovering virus-host protein interactions. EMBO Rep (2013) 0.83
Characterization of hepatitis C virus pseudoparticles by cryo-transmission electron microscopy using functionalized magnetic nanobeads. J Gen Virol (2010) 0.83
Pharmacotherapy of anxious disorders. Hum Psychopharmacol (2002) 0.82
High-density lipoprotein phospholipids interfere with dendritic cell Th1 functional maturation. Immunobiology (2011) 0.82
Physicochemical parameters of non-viral vectors that govern transfection efficiency. Curr Gene Ther (2008) 0.82
Transmission of low-density hepatitis C viral particles during sexually transmitted acute resolving infection. J Med Virol (2008) 0.82
Modulation of gene expression as a new skin anti-aging strategy. J Drugs Dermatol (2007) 0.81
Relationships between the physicochemical properties of an amphiphilic triblock copolymers/DNA complexes and their intramuscular transfection efficiency. Nucleic Acids Res (2006) 0.81
Galactosylated multimodular lipoplexes for specific gene transfer into primary hepatocytes. J Gene Med (2008) 0.81
Treatment of acute mania--from clinical trials to recommendations for clinical practice. Hum Psychopharmacol (2005) 0.81
Glucosyloxybenzyl eucomate derivatives from Vanda teres stimulate HaCaT cytochrome c oxidase. J Nat Prod (2011) 0.81
In vitro studies reveal that different modes of initiation on HIV-1 mRNA have different levels of requirement for eukaryotic initiation factor 4F. FEBS J (2012) 0.81
Natural polymorphisms in HIV-1 protease: impact on effectiveness of a first-line lopinavir-containing antiretroviral therapy regimen. J Med Virol (2008) 0.81
Human Polycomb group EED protein negatively affects HIV-1 assembly and release. Retrovirology (2007) 0.81
Bioactive molecules in Kalanchoe pinnata leaves: extraction, purification, and identification. Anal Bioanal Chem (2010) 0.81
Metallic oxide nanoparticle translocation across the human bronchial epithelial barrier. Nanoscale (2015) 0.81
Two-dimensional structures of the Shiga toxin B-subunit and of a chimera bound to the glycolipid receptor Gb3. J Struct Biol (2002) 0.80
Probing the in vitro mechanism of action of cationic lipid/DNA lipoplexes at a nanometric scale. Nucleic Acids Res (2010) 0.80
Modeling leakage kinetics from multilamellar vesicles for membrane permeability determination: application to glucose. Biophys J (2006) 0.80
Organization of reconstituted lipoprotein MexA onto supported lipid membrane. Eur Biophys J (2007) 0.80
Skin ageing: clinical and histopathologic study of permanent and reducible wrinkles. Eur J Dermatol (2002) 0.80
Amphiphilic block copolymers enhance the cellular uptake of DNA molecules through a facilitated plasma membrane transport. Nucleic Acids Res (2010) 0.79
Different molecular arrangements of the tetrameric annexin 2 modulate the size and dynamics of membrane aggregation. Biochim Biophys Acta (2010) 0.79